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Background: The sustainable production of biofuels remains one of the major issues of the upcoming years.
Among the number of most desirable molecules to be produced, butanol and isobutanol deserve a prominent
place. They have superior liquid-fuel features in respect to ethanol. Particularly, butanol has similar properties to
gasoline and thus it has the potential to be used as a substitute for gasoline in currently running engines. Clostridia
are recognized as natural and good butanol producers and are employed in the industrial-scale production of
solvents. Due to their complex metabolic characteristics and to the difficulty of performing genetic manipulations,
in recent years the Clostridia butanol pathway was expressed in other microorganisms such as Escherichia coli and
Saccharomyces cerevisiae, but in yeast the obtained results were not so promising. An alternative way for producing
fusel alcohol is to exploit the degradation pathway of aminoacids released from protein hydrolysis, where proteins
derive from exhausted microbial biomasses at the end of the fermentation processes.
Results: It is known that wine yeasts can, at the end of the fermentation process, accumulate fusel alcohols, and
butanol is among them. Despite it was quite obvious to correlate said production with aminoacid degradation, a
putative native pathway was never proposed. Starting from literature data and combining information about
different organisms, here we demonstrate how glycine can be the substrate for butanol and isobutanol production,
individuating at least one gene encoding for the necessary activities leading to butanol accumulation. During a
kinetic of growth using glycine as substrate, butanol and isobutanol accumulate in the medium up to 92 and
58 mg/L, respectively.
Conclusions: Here for the first time we demonstrate an alternative metabolic pathway for butanol and isobutanol
production in the yeast S. cerevisiae, using glycine as a substrate. Doors are now opened for a number of
optimizations, also considering that starting from an aminoacid mixture as a side stream process, a fusel alcohol
blend can be generated.
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The production of biofuels from renewable biomasses is
one of the answers to help solving the problems associ-
ated with limited fossil resources and climate changes.
Butanol has superior liquid-fuel characteristics in respect
to ethanol, similar properties to gasoline, and thus it has
the potential to be used as a substitute for gasoline in
currently running engines [1].
Clostridia are recognized as natural and good butanol
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distribution, and reproduction in any mediumproduction of solvents [2]. However, the complex meta-
bolic characteristics and the difficulty of performing gen-
etic manipulations on these bacteria fostered the
exploitation of other well established cell factories. In re-
cent years, Escherichia coli and Saccharomyces cerevisiae
were engineered with the Clostridia butanol pathway
[3,4]. While many optimizations have been successfully
introduced in E. coli [5-8] reaching productions similar
to that obtained in Clostridia [9], this was up to now not
reported for the budding yeast. For an exhaustive view
of the metabolic strategies applied for butanol and other
fusel alcohol production see [10,11] and references
therein. Remarkably, Liao et al. proposed that proteins,
and thus the aminoacids released from proteins hydrolysis,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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biofuels production. Indeed, proteins are abundantly
present as final waste of lignocellulose processing [12]. We
focused our attention on the strategy which takes advan-
tage of ketoacids as intermediates in amino acids biosyn-
thesis and degradation metabolism to produce fusel
alcohols in the yeast S. cerevisiae. While the pathway to
isoketovalerate was better elucidated and recently success-
fully exploited for isobutanol formation in S. cerevisiae
[13-17], butanol production from ketovalerate was never
experimentally measured.
S. cerevisiae have one or more carrier systems specific
for each aminoacid, even if they are not all currently
known. Among them, the general aminoacids permease,
encoded by GAP1 gene, is involved in glycine transport
[18]. In the cytosol glycine can be catabolised in differ-
ent ways, based on nutritional requirements. For ex-






























Figure 1 A novel pathway for butanol and isobutanol production. Me
S. cerevisiae through the glyoxylate, β-ethylmalate and α-ketoacids interme
the associated gene(s) are also represented. Numbers inside circles indicate
isomerisation of α-ketovalerate into α-isoketovalerate is indicated by blackhydroxymethyltransferase enzyme (Shm2) [19] or into
CO2 and NH3 through the enzymatic complex of glycine
decarboxylase enzyme (GDC) [20].
Villas-Bôas and co-workers [21] have in silico pro-
posed the generation of glyoxylate as a consequence of
glycine deamination. Moreover, the authors described
the formation of α-ketovalerate and α-isoketovalerate as
intermediates of the same pathway through not identi-
fied reactions. Starting from these indications and know-
ing from literature that α-ketovalerate can be converted
into butanol [22], and that α-isoketovalerate can be
converted into isobutanol [23], we cultivated yeast cells
with glycine, observing the formation of both alcohols. By
deeply investigating the literature, we have first (i) hypothe-
sized and then (ii) biochemically demonstrated step by step
the butanol and isobutanol production through the glycine
degradation pathway via glyoxylate and α-ketoacids inter-
mediates (Figure 1). Additionally, we suggest at least oneylate 
le
boxylase (PDC1, 5, 6)          
















tabolic pathway for butanol and isobutanol production from glycine in
diates (grey background arrows). The enzymatic activities involved and
s the steps of the pathway discussed in this study. The hypothesized
arrow.
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butanol production.
Glycine deaminase has been hypothesized to catalyze
the glycine conversion into glyoxylate [21], the first step of
the pathway. In S. cerevisiae the gene encoding for this en-
zyme has not been annotated yet. However, Bacillus
subtilis gene goxB [24] encodes for a glycine oxidase that
can catalyze this conversion (Figure 1, circle 1). For the
second step, similarly to what happens in Pseudomonas
aeruginosa [25], we hypothesized the glyoxylate condensa-
tion with butyryl-CoA to yield the β-ethylmalate inter-
mediate (Figure 1, circle 2). β-ethylmalate might be then
converted into α-ketovalerate through a β-isopropylmalate
dehydrogenase enzyme (Figure 1, circle 3), as described
in E. coli [22]. The final step is well depicted by the
Ehrlich pathway: the α-ketovalerate is converted into
butanol through a reductive decarboxylation reaction
[26] (Figure 1, circles 4 and 6).
Summarizing, the single steps of the proposed pathway
have been already described in literature, even if in dif-
ferent pathways and from different microorganisms:
moreover, in some cases indications were provided only
as enzymatic reactions. In this work we demonstrate that
in the yeast S. cerevisiae thanks to these reactions gly-
cine can be converted into butanol.
Results and discussion
Butanol and isobutanol can be obtained from glycine
All the production experiments described here and in
the next paragraphs were performed in two different S.
cerevisiae genetic background, BY and CEN.PK (see
Methods for further details), proving the production of
butanol and isobutanol from glycine. Here we show bu-
tanol and isobutanol kinetics and titers related to the
CEN.PK background. It has to be underlined that the
production levels obtained in the BY4741 background
were consistent, but always lower. Because of the con-
venience of using single gene deletion mutants available
from the Euroscarf collection, all the experiments related
to the characterization of the enzymatic activities were









































Figure 2 Butanol and isobutanol accumulation from glycine. Yeast cel
left panel) or glycine (15 g/L, right panel) as nitrogen source. Biomass accu
isobutanol (diamond) productions are shown. The data presented here areYeast cells were grown in minimal defined medium
and in the same medium but using glycine (15 g/L) in-
stead of ammonium sulphate as nitrogen source (see
Methods for details). The substitution was preferred to
the addition to promote the glycine uptake, a poor nitro-
gen source if compared to ammonium sulphate, glutamine
or glutamate [27]. Butanol and isobutanol accumulations
were evaluated at different time point after the inoculum
(Figure 2). We confirmed that butanol does not accumu-
late in minimal ammonium sulphate medium, while
isobutanol does (left panel diamond symbols, 46.5 mg/L),
since it can derive from other pathways (see Figure 1).
When glycine is added as substrate, both butanol and
isobutanol accumulate over time, reaching a registered
maximum of 92 and 58 mg/L, respectively (Figure 2, right
panel), together with a glycine consumption. The de-
scribed experiment indicates therefore that (i) the butanol
production requires glycine as substrate and that (ii) the
measured isobutanol might only partially derive from the
glycine degradation pathway.
In the following sections we characterize the proposed
pathway step by step. The substrates used are glycine,
glyoxylate, α-ketovalerate and α-isoketovalerate. Unfor-
tunately, the intermediate β-ethylmalate is not commer-
cially available and for this reason a coupled enzymatic
reaction starting from glyoxylate as initial substrate was
planned to circumvent this problem.
The first reaction of the pathway: from glycine to
glyoxylate
The first step is the conversion of glycine to glyoxylate,
by a glycine deaminase activity [21]. Since no genes are
annotated in yeast encoding for this function and being
the identification of a putative gene encoding for the de-
sired function not trivial, we searched for a similar activ-
ity in other microorganisms. It has been described that
in B. subtilis the glycine conversion into glyoxylate is
catalyzed by the glycine oxidase enzyme, encoded by
goxB gene, Figure 3A. This enzyme catalyzes the primary
amines oxidative deamination to yield the corresponding









































ls were grown in Verduyn medium with ammonium sulphate (5 g/L,
mulation (square), glycine consumption (triangle), butanol (circle) and






































































BuOH IsoBuOH GoxB activity
Figure 3 Glycine oxidase: reaction and enzymatic activity assay. (A) Reaction catalysed by glycine oxidase. The carbons of the molecules
were numbered. (B) Glycine oxidase activity (upper bars), butanol (dark gray columns) and isobutanol (pale gray columns) for the wild type and
modified yeast strains overexpressing the bacterial goxB gene optimized for the yeast codon usage. The data presented here are representative of
three independent experiments.
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homotetrameric flavoprotein which effectively catalyzes the
oxidation of sarcosine (N-methylglycine), N-ethylglycine
and glycine. Lower activities using D-alanine, D-valine, and
D-proline as substrates were described although no activ-
ities were shown on L-amino acids and other D-amino
acids [24]. Consequently, the B. subtilis goxB gene was syn-
thesized with an optimized codon usage (see Additional file
1) for S. cerevisiae (goxB opt) and constitutively expressed
in yeast. The heterologous enzymatic activity was tested
using an in vitro assay for glycine oxidase (as described in
the Methods section [28]), Figure 3B. As expected, in the
control (transformed with the empty vector) as well as in
the goxB opt overexpressing strains the assay revealed the
desired activity, being 1.5 fold higher in the recombinant
yeast. It has to be mentioned that overall the measured
activities are quite low: however, it might be that the
assay needs to be optimized. In fact, the activity mea-
sured in total protein extract from E. coli BL21 strain
overexpressing the B. subtilis goxB gene was ~ 4.E-03 U/mg
proteins (corresponding to ~ 0.004 U/mL), against 0.4 U/mL
reported in literature for the purified enzyme [28].
The effect of glycine oxidase overexpression on buta-
nol and isobutanol accumulation was preliminary tested
in the two yeast genetic backgrounds, grown like de-
scribed for Figure 2. In both cases, in the strains
overexpressing the goxB opt gene we observed a higher
butanol and isobutanol accumulation, being about 30%
and 15%, respectively (Figure 3, dark and pale gray col-
umns, respectively). The data prove that an activityresponsible for glycine conversion into glyoxylate is the
first step leading to butanol accumulation, and we also
show a first example of how to improve said activity
(Figure 3, upper bars).
The second reaction of the pathway: from glyoxylate to
β-ethylmalate
In yeasts, no activity able to catalyze the condensation of
glyoxylate with butyryl-CoA to form β-ethylmalate has
been described yet. However, the malate synthase en-
zyme catalyzes a similar reaction: the glyoxylate conden-
sation with acetyl-CoA to form malate [29]. In S.
cerevisiae two isoforms of malate synthase are described,
encoded by MLS1 and DAL7 genes [29]. MLS1 expres-
sion is repressed by glucose and induced when cells are
growing on non-fermentable carbon sources, such as
fatty acid, ethanol or acetate. DAL7 encodes for an en-
zyme recycling the glyoxylate generated during allantoin
degradation. Its expression is controlled by the nitrogen
source present in the medium, resulting repressed in the
presence of rich nitrogen sources, such as asparagine
and ammonium, and derepressed in the presence of
poor nitrogen sources, such as proline [29]. We hypoth-
esized first and then evaluated if butyryl-CoA could also
be a substrate of malate synthase enzyme, considering
the structural analogy with acetyl-CoA, Figure 4A.
Yeasts were grown in rich YPD medium and malate
synthase activity was detected in the presence of acetyl-
CoA or butyryl-CoA as acyl-CoA donors, using a modi-




















































   
   
   
   






















   
   
   
   




























Figure 4 Malate synthase activity and glyoxylate bioconversion into butanol and isobutanol. (A) Glyoxylate conversion reaction
performed by malate synthase enzyme in the presence of butyryl-CoA. The carbons of the molecules were numbered. (B) Malate synthase
activity for the glyoxylate conversion into β-ethylmalate. Left panel: malate synthase activity was assayed using acetyl-CoA or butyryl-CoA as
donor group. Right panel: effect of MLS1 deletion on the enzymatic activity. The data presented here are representative of three independent
experiments. p≤ 0,05 = *; p≤ 0,01 = **; p ≤ 0,001 = ***; p > 0,05 = n.s. (C) Glyoxylate bioconversion. Butanol (full columns) and isobutanol (empty
columns) production as well as glyoxylate consumption (triangle) measured at different time point. The data presented here are representative of
three independent experiments.
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tion in which both Mls1 and Dal7 were present at simi-
lar level, as reported in literature [29]. Remarkably, when
butyryl-CoA was added as acyl-CoA donor a malate
synthase activity was detected, even if at lower value if
compared to the activity measured in the presence of
acetyl-CoA (1 U/mg proteins versus 2 U/mg proteins, re-
spectively). Based on our information, this is the first ex-
perimental evidence that a yeast malate synthase can accept
butyryl-CoA as acyl-CoA donor. The MLS1 deletion nega-
tively affects the activity (about 25% of reduction, Figure 4B,
right panel) and the same impairment is caused by DAL7
deletion (data not shown), suggesting that the two enzymes
might similarly contribute to the reaction of interest.
If our hypothesis is correct, feeding the cells with
glyoxylate should result in butanol and isobutanol accumu-
lation. To determine favourable production conditions,
yeast cells were grown in minimal medium in the absenceor presence of different amount of glyoxylate (0.5, 1, 5 g/L)
at different pH (2.5 and 5.5) values. Figure 4C confirms the
butanol and isobutanol accumulation, not detectable if
glyoxylate is absent (data not shown). In the reported ex-
ample the production was obtained starting with 5 g/L of
glyoxylate at pH 2.5. This pH value has been selected to fa-
cilitate the diffusion of undissociated glyoxylic acid inside
the cells, since no carrier for this metabolite is reported in
literature. In this condition the glyoxylate was almost to-
tally consumed. Cells accumulated during the time about
20 and 30 mg/L of butanol and isobutanol, respectively.
This confirms the involvement of glyoxylate as intermedi-
ate in the formation of the desired alcohols. At the mo-
ment we have no explanation for the higher isobutanol
accumulation. One possibility could be that in case of high
amount of glyoxylate, Agx1 [30] catalyzes its conversion
into glycine, shifting the reaction trough serine formation
(see Figure 1).
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α-ketovalerate
In E. coli the β-isopropylmalate dehydrogenase enzyme,
encoded by the leuB gene, catalyzes the conversion of β-
isopropylmalate into α-ketoisocaproate. Shen and Liao
[22] have demonstrated the possibility to use this enzyme
to additionally catalyze the conversion of β-ethylmalate
into α-ketovalerate in E. coli cells (the reaction is depicted
in Figure 5A). LEU2 is the homologous of leuB in S.
cerevisiae [31]. Therefore, by using the BY4741 strain
(deleted in LEU2) and the same strain transformed with a
LEU2 multicopy plasmid, we tested the contribution of
the Leu2 activity in the novel pathway. The activity assay
was performed using two coupled reactions, since β-
ethylmalate is not commercially available. In the first reac-
tion, glyoxylate and butyryl-CoA should be converted into
β-ethylmalate by the malate synthase activity, as described
in the previous paragraph. The second coupled reaction,
catalyzed by the Leu2 activity, utilizes the produced β-
ethylmalate to generate α-ketovalerate and releasing
NADH as reduced equivalent. Said cofactor can be spec-
trophotometrically measured to determine the activity. In
the LEU2 overexpressing strain the activity was about 5









































Figure 5 The β-isopropylmalate dehydrogenase involvement in the g
activity was tested in a coupled reaction using glyoxylate as substrate inste
molecules were numbered. (A) Reaction catalysed by the β-isopropylmalat
dehydrogenase measured in yeast strain ΔLEU2 (empty column) and overe
representative of three independent experiments. p≤ 0,05 = *; p≤ 0,01 = **0.1 and 0.02 U/mg proteins, respectively (Figure 5B).
When MLS1 or DAL7 are deleted while Leu2 is present, the
dehydrogenase activity significantly decreases, confirming
that β-ethylmalate is the substrate of the reaction (Table 1).
Table 1 reports all the combinations tested and the regis-
tered activities. Interestingly, the residual activity detected
whenever LEU2 is deleted suggests that other(s) activity(ies)
might be responsible for β-ethylmalate conversion.
Concluding, these data indicate that the presence of
LEU2 coupled with malate synthase activity guarantees
the glyoxylate conversion into α-ketovalerate.
The last step: from α-ketoacids to butanol and isobutanol
The last step necessary in the glycine degradation to pro-
duce the desired alcohols is the reductive decarboxylation
of α-ketovalerate into butanol and of α-isoketovalerate into
isobutanol, Figure 6A.
The conversion of α-ketovalerate into α-isoketovalerate
was proposed to occur through a dehydratation reaction,
catalyzed by dihydroxyacid dehydratase enzyme [21].
However, at the best of our information, no experimental
evidences are reported up to now. By looking at the chem-
ical structure of the two ketoacids, this reaction might re-














lycine degradation pathway. The β-isopropylmalate dehydrogenase
ad of β-ethylmalate (not commercial available). The carbons of the
e dehydrogenase enzyme. (B) Activity of β-isopropylmalate
xpressing LEU2 gene (grey column). The data presented here are
; p≤ 0,001 = ***; p > 0,05 = n.s.
Table 1 β-Isopropylmalate dehydrogenase activity
measured with assay coupling the reactions catalyzed by
Mls1 and Leu2
Gene β-IPMD Activity
(U/mg prot)MLS1 DAL7 LEU2
+ + ++ 0.098 ± 0.010
+ + - 0.023 ± 0.001
+ - ++ 0.019 ± 0.002
+ - - 0.016 ± 0.002
- + ++ 0.021 ± 0.002
- + - 0.018 ± 0.002
The symbols “+” indicate the wild type copy or “++” the overexpression of the
corresponding gene in the table. The symbol “-” indicate the deletion of the
gene. The data presented here are representative of three
independent experiments.
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two reactions: in the first one α-ketovalerate decarboxyl-
ation generates the corresponding aldehyde; in the sec-
ond one the aldehyde is reduced to alcohol, butanol in
this case (Figure 6A, upper part). It was reported that in
S. cerevisiae α-keto-β-methylvalerate, α-ketoisocaproate
and α-isoketovalerate [32] can be decarboxylated to the
α-ketoacids by pyruvate decarboxylases (Pdc). Going
one step forward, Brat et al. reported that through the
α-isoketovalerate decarboxylation isobutanol can be
produced [16], starting from valine as substrate. How-
ever, to avoid co-current pyruvate decarboxylation into
ethanol, the authors replaced the PDC genes with the
decarboxylase encoded by ARO10 gene, which has no
activity on pyruvate [16].
Yeast no data are available about a possible α-
ketovalerate decarboxylation in yeast. When pyruvate,
α-ketovalerate and α-isoketovalerate were used as sub-
strates, the activities measured using an assay for Pdc
activity were 722 ± 2.3, 1.75 ± 0.3 and 0.3 ± 0.05 U/mg
proteins, respectively. The involvement of pyruvate de-
carboxylase in the last reaction was also demonstrated by
measuring the butanol and isobutanol production in a
PDC1, 5, 6 deleted strain. In the presence of α-ketovalerate
(1.1612 g/L, 10 mM) as substrate, the deletion of all three
isoforms of pyruvate decarboxylase significantly decreases
the butanol and isobutanol production, as shown in bio-
conversion experiment (Figure 6B). In particular, the buta-
nol titer was 5 times lower than in wild type strain, 118
versus 583 mg/L respectively. By incubating the triple PDC
deleted strain with α-isoketovalerate no isobutanol accu-
mulation was observed (data not shown).
It is important to underline that in the presence of α-
ketovalerate as substrate both butanol and isobutanol
are produced (Figure 6C, left panel) in wild type strain.
Considering that more isobutanol is obtained when gly-
cine is added to glucose minimal medium (Figure 2), we
could hypothesize that α-isoketovalerate might partiallyderive from α-ketovalerate and that this reaction is prob-
ably irreversible, since in the presence of α-isoketovalerate
only isobutanol accumulation was observed (Figure 6C,
right panel).
The glyoxylate conversion into butanol and isobutanol
requires Mls1, Leu2 and Pdc(s) activities
To further prove the link between glycine and the fusel
alcohols we developed an in vitro assay in which all reac-
tions of the proposed pathway are coupled. To perform
this assay we measured the pyruvate decarboxylase activ-
ity using glycine as substrate, monitoring the decrement
of OD340nm since NADH is consumed during the last re-
action. No data were obtained. We believe that this
could be related to (i) a lower conversion of glycine to
glyoxylate and/or to (ii) the very different physio-
chemical assay conditions required by glycine oxidase
(the first enzyme of the pathway) in respect to all the
other enzymes. Indeed, a Pdc activity was detected when
glyoxylate was used as substrate, confirming the conver-
sion of glyoxylate to the α-ketovalerate.
Figure 7 shows the complete panel of the Pdc activities
measured in the different strains. The higher activity
was registered in the wild type strain overxpressing the
LEU2 gene, the minimal (almost undetectable) in the
double MLS1/LEU2 deleted strain and an intermediate
situation when only one of the two genes was deleted.
To be more precise, the LEU2 deletion affects more the
activity, very likely because in the case of MLS1 deletion,
Dal7 is able to replace its function (and vice versa) [29].
Conclusions
This study describes a novel pathway to produce butanol
and isobutanol in the yeast S. cerevisiae through the gly-
cine degradation pathway.
We characterized the entire pathway identifying for
each step at least one enzymatic reaction with at least
one relative gene for butanol production. 92 mg/L of bu-
tanol were produced starting from glycine as substrate.
It might be speculated that butanol derives from
butyryl-CoA and that glycine is solely used to drive the
flux. Remarkably, the proposed pathway implies catalytic
reactions that justify how glycine is not simply burnt to
carbon dioxide, but is an effective co-substrate for the
butanol production, as highlighted by the numbered car-
bons (see Figures 3, 4, 5 and 6, panels A).
Despite the yield on glycine is still quite low, it should
be underlined that butanol was obtained through en-
dogenous activities which are in general involved in
other reactions and specific for other substrates. There-
fore, it can be anticipated that there are many different
possibilities for optimizing the pathway, considering














































































































































Figure 6 Pyruvate decarboxylase activity and α-ketoacids bioconversion into butanol and isobutanol. (A) α-ketovalerate and
α-isoketovalerate conversion reaction performed by pyruvate decarboxylase enzyme. The carbons of the molecules were numbered. (B) Pyruvate
decarboxylase deletion effect on butanol and isobutanol accumulation using α-ketovalerate as substrate. Wild type (empty column) and PCD1, 5, 6
deleted strains (full column). The data presented here are representative of three independent experiments. p≤ 0,05 = *; p≤ 0,01 = **; p≤ 0,001 =
***; p > 0,05 = n.s. (C) α-Ketovalerate (left panel) and α-isoketovalerate (right panel) bioconversion. Butanol (dark grey), isobutanol (white) and
α-ketovalerate consumption (triangle) were reported. For α-isoketovalerate (triangle), the sole estimated initial concentration is given. The data
presented here are representative of three independent experiments.
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http://www.biotechnologyforbiofuels.com/content/6/1/68From an economical point of view the production of
higher alcohols starting from purified glycine cannot be
considered as a sustainable process. Metabolic engineering
and synthetic biology can then help in the construction of
a yeast redirecting sugars to glycine production, and from
there to optimize the sole butanol production, but this ap-
pears at the moment as a long way to run. However, an
alternative seems closer to reality: a considerable fraction
of proteins accumulate as waste product deriving from
exhausted biomasses of different microbial productionsand currently is not fully absorbed by the market [12]. It is
then possible to imagine a side-stream process of produc-
tion which is based on protein hydrolysates; the different
aminoacids fed to a yeast strain optimized for desired fusel
alcohol production could generate a blend with good
properties as biofuel [12], adding value and completing
the concept of biorefinery.
Considering the potentiality of S. cerevisiae as ethanol
producer and considering the potentiality of the aminoacid



















   
   
   
   
   










Figure 7 The evidence of glyoxylate degradation through the
Mls, β-IPMD and Pdc(s) activities. The MLS1 deletion effect was
evaluated coupled with the LEU2 deletion or overexpression
(respectively indicated as ΔMLS1ΔLEU2 and ΔMLS1 LEU2). The data
presented here are representative of three independent experiments.
p≤ 0,05 = *; p≤ 0,01 = **; p≤ 0,001 = ***; p > 0,05 = n.s.
Table 2 Strains and plasmids used in this work
Parental strain
Strain Genotype
CEN.PK 102-5B MATa, ura3-52, his3-11, leu2-3/112, TRP1, MAL2-8c, SUC2
CEN.PK RWB837 MATa, pdc1::loxP, pdc5::loxP, pdc6::loxP, ura3-52
BY4741 MATa, ura3Δ0, leu2Δ0, met15Δ0, his 3Δ1
BY4741ΔMLS1 MATa; his3 Δ1; leu2 Δ0; met15 Δ0; ura3 Δ0; YNL117w::
kanMX4






pYX212 multicopy (2μ derived) URA3
pYX212goxB opt multicopy (2μ derived) URA3, optimised goxB
pYX022 integrative HIS3
pYX242 multicopy (2μ derived) LEU2
Transformed strain
Strain Plasmid Obtained strain
CEN.PK 102-5B pYX212, pYX022, pYX242 CEN.PKc
BY4741 pYX212, pYX022, pYX242 BY4741c
BY4741 pYX212goxB opt, pYX022,
pYX242
BY4741c goxB opt
BY4741ΔMLS1 pYX212, pYX022, pYX242 BY4741ΔMLS1c




BY4741ΔDAL7 pYX212, pYX022, pYX242 BY4741ΔDAL7c
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studying and improving yeast tolerance to a mixture of dif-
ferent organic solvents.
Methods
Strains and growth conditions
The S. cerevisiae strains used in this study were CEN.PK
102-5B (MATa,ura3-52, his3-11, leu2-3/112, TRP1, MAL2-
8c, SUC2 - Dr. P. Kötter, Institute of Microbiology, Johann
Wolfgang Goethe-University, Frankfurt, Germany) [33]
and BY4741 (MATa, ura3Δ0, leu2Δ0, met15Δ0, his 3Δ1)
(EUROSCARF collection, Heidelberg, Germany). The
strains BY4741ΔMLS1 (MATa; his3 Δ1; leu2 Δ0; met15 Δ0;
ura3 Δ0; YNL117w::kanMX4) and BY4741ΔDAL7 (MATa;
his3 Δ1; leu2 Δ0; met15 Δ0; ura3 Δ0; YIR031c::kanMX4)
are provided by EUROSCARF deleted strain collection
(EUROSCARF collection, Heidelberg, Germany). The
strain deleted in all three isoform of pyruvate decarboxyl-
ase (ΔPDC1, 5, 6) is CEN.PK RWB837 (MATa; pdc1::
loxP, pdc5::loxP, pdc6::loxP, ura3-52) [34]. Strains
designed with “c” correspond to the respective parental
strain transformed with empty plasmid(s) (see below)
to render them prototrophic. Strains designed with
“goxB opt” are the corresponding parental strain
transformed with plasmid pYX212 (see below) with the
B. subtilis goxB coding sequence optimized for the S.
cerevisiae codon usage. goxB opt gene was expressed
under the control of the S. cerevisiae TPI1 promoter.
Yeast transformations were performed according to the
LiAc/PEG/ss-DNA protocol [35]. All the parental and
transformed strains are reported in the Table 2.
Media composition for cell growth and bioconversion
Independent transformants and the respective control
strains (at least three for each transformation) werecultivated in shake flasks with 5/1 ratio of flask volume/
medium in minimal synthetic medium with 20 g/L of
glucose and supplemented with glycine, glyoxylate, α-
ketovalerate or α-isoketovalerate, as specifically indicated
in the experiments. YPD and YPGE (for the triple PDC
deleted strains) media were prepared as follows: yeast ex-
tract 1% (w/v), tryptone 2% (w/v) and glucose 2% (w/v) for
the YPD. In the YPGE the glucose was replaced with gly-
cerol 1% (v/v) and ethanol 1% (v/v). All strains were
grown at 30°C on orbital shaker at 160 rpm for 72 hours.
Kinetic experiment
The butanol and isobutanol production starting from
glycine (Figure 2) was performed by growing the cells in
Verduyn medium [36] with glucose 20 g/L and glycine
15 g/L as substrates.
Bioconversion experiment
The bioconversion experiments were performed in two
phases: 1) cells were grown in YPD or YPGE (for the
triple PDC deleted strains) medium until the stationary
phase; 2) cells were collected by centrifugation (10 min
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appropriate medium to perform the bioconversion phase.
The medium for glyoxylate bioconversion (Figure 4C) was
minimal synthetic medium with glucose 20 g/L and
glyoxylate 5 g/L at pH 2.5. The medium for α-ketovalerate
(or α-isoketovalerate) bioconversion (Figure 6C) was
minimal synthetic medium with glucose 20 g/L and α-
ketovalerate (or α-isoketovalerate) 1.1612 g/L (corre-
sponding to 10 mM).
Gene amplification and plasmids construction
The B. subtilis goxB gene was designed with codon usage
adaptation for S. cerevisiae by Eurofins MWG Operon.
In the Additional file 1 was reported the complete se-
quence of goxB synthesized. goxB opt gene was
subcloned into the multicopy yeast expression plasmid
pYX212 (R&D Systems, Inc., Wiesbaden, D, URA3
marker), resulting in the plasmid pYX212goxB opt. The
heterologous gene is under the control of the S.
cerevisiae TPI1 promoter. For the construction of the
plasmid pYX212goxB opt, the recipient vector was EcoRI
cut, blunted and dephosphorylated, while the insert was
EcoRI blunt excised from the Eurofins plasmid. DNA
manipulation, transformation and cultivation of E. coli
(Novablue, Novagen) were performed following standard
protocols [37]. All the restriction and modification en-
zymes utilised are from NEB (New England Biolabs, UK)
or from Roche Diagnostics.
Cell growth and metabolites determination
The cellular growth was spectrophotometrically moni-
tored at 660nm and was reported as variation of the op-
tical density (OD) as a function of time (h). The amount
of extracellular glucose, butanol, isobutanol, glyoxylate
and α-ketovalerate were determined by HPLC based
method using H2SO4 5 mM as mobile phase and
Aminex HPX-87P column, 300 × 7.8 mm with a poly-
styrene divinylbenzene-based matrix (BioRad). The gly-
cine quantification was performed using a previously
described assay [38].
Determination of enzymatic activities
Exponentially growing cells were harvested by centrifu-
gation at 4000 rpm for 10 min and washed with cold
deionised water. The cell pellet was then re-suspended
in 25 mM Tris-HCl pH 8.0 with protease inhibitor cock-
tail (Roche diagnostics, Cat. No. 04906837001) and 1 mM
of phenylmethylsulfonyl fluoride (PMSF) and mechanic-
ally disrupted using glass microbeads (600 μm, Sigma-
Aldrich). Cells debris was removed by centrifugation at
14000 rpm for 10 min at 4°C and the clarified crude ex-
tract was used for enzymatic analysis. The protein concen-
tration in cell-free extracts was estimated according to
Bradford [39] using bovine serum albumin as reference.Enzyme activities were measured on cell-free extracts
by spectrophotometric assays. Activities were expressed
as U/mg of total proteins.
Glycine oxidase activity
Glycine oxidase activity was assayed spectrophotometric-
ally via determination of H2O2 with an enzyme-coupled
assay using horseradish peroxidase and o-dianisidine, as
previously described with some modifications [28]. The
assay was performed on a final volume of 1 ml as follows:
Tris-HCl 100 mM pH 8, phosphoric acid 10 mM,
glycine 50 mM, o-dianisidine 1 mM, FAD 0.198 μM,
horseradish peroxidase 14.72 U/mL, cell-free protein
extract (0.5 mg/mL). The reaction was incubated at
37°C for 90 minutes and yellow colour, developed by
o-dianisidine oxidation, was monitored at 530 nm. The
glycine oxidase activity was expressed as U/mg of total
proteins using the following equation:
Activity U=mg prot totð Þ
¼ OD 530nm=minð Þ=εð Þ ⋅dilution factorð Þ=mg prot tot
Were ε = 8.3 · 1/(mM · cm)
One glycine oxidase unit is defined as the amount of
enzyme that converts 1 mole of substrate (glycine) per
minute at 25°C.
Malate synthase activity
The malate synthase activity was performed as described
in Sigma-Aldrich protocol [40] using acetyl-CoA (or
butyryl-CoA) + glyoxylate. The assay take into consider-
ation that glyoxylate condensation with acetyl-CoA (or
butyryl-CoA) produces malate (or β-ethylmalate) and
CoA. The free CoA can react with the Ellman reagent
DTNB (5,5'-Dithio-bis(2-Nitrobenzoic Acid)) which re-
acts with free thiol groups, producing CoA-derivative
and TNB (5-Thio-2-Nitrobenzoic Acid) [41]. The quan-
tity of TNB produced is in stoichiometric ratio (1:1) with
free thiol groups and was monitored spectrophotomet-
rically at 412 nm.
β-isopropylmalate dehydrogenase activity (using glyoxylate
and butyryl-CoA as substrates)
The β-isopropylmalate dehydrogenase enzyme catalyzes
the NAD-dependent oxidation of the substrate with sim-
ultaneously conversion of NAD+ to NADH. The activity
was spectrophotometrically determined at 340 nm. The
assay was performed on a final volume of 1 mL in cu-
vette with imidazole 50 mM pH 8, MgCl2 10 mM,
butyryl-CoA 0.125 mM, glyoxylate 0.5 mM, NAD+ 1.575
mM. After incubation at 30°C for 10 min cell-free pro-
tein extract (0.6 mg/mL) were added and increasing of
absorbance at 340 nm was monitored for 10 min.
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expressed as U/mg total proteins using the following
equation:
Activity U=mg prot totð Þ
¼ OD 340nm=min ⋅dilution factorð Þ=ε ⋅Ev
Were ε is the millimolar extinction coefficient of
NADH at 340 nm (6.22 · 1/(mM · cm)) and Ev is the vol-
ume of cell extract used (expressed in millilitres).
Pyruvate decarboxylase activity (using glycine or glyoxylate
and butyryl-CoA as substrates)
The pyruvate decarboxylase enzyme catalyzes the de-
carboxylation of ketoacid to form the derived aldehyde
which is reduced by alcohol-dehydrogenase NADH-
dependent activity. The conversion of NADH to NAD+
is spectrophotometrically revealed at 340 nm.
The assay was performed based on pyruvate decarboxyl-
ase assay protocol of Sigma-Aldrich [40] with some modi-
fications. When glycine was used as substrate Tris-HCl
100 mM pH 8, phosphoric acid 10 mM, glycine 50 mM,
FAD 0.198 μM, MgCl2 10 mM, butyryl-CoA 0.125 mM
and NADH 0.16 mM were added in cuvette in a final vol-
ume of 1 mL. After incubation at 37°C for 30 minutes, al-
cohol dehydrogenase enzymatic solution (200 U/mL) and
0.2 mg/mL of cell-free extract were added. The decrease
of absorbance at 340 nm was monitored for 15–30 min.
When glyoxylate and butyryl-CoA were used as sub-
strates imidazole buffer 35 mM, MgCl2 10 mM, butyryl-
CoA 0.125 mM, glyoxylate 0.5 mM and NADH 0.16 mM
were added in cuvette in a final volume of 1 mL. After
incubation at 30°C for 10 min 20 μL of alcohol dehydro-
genase enzyme solution (200 U/mL) and 0.2 mg/mL of
cell-free extract were added. The decrease of absorbance
at 340 nm was monitored for 15 min.
The activity was expressed as U/mg total proteins
using the following equation: Activity (U/mg prot tot) =
(OD 340nm/min · dilution factor)/ε · Ev.
Were ε is the millimolar extinction coefficient of
NADH at 340 nm (6.22 · 1/(mM · cm)) and Ev is the vol-
ume of cell extract used (expressed in millilitres).
Additional file
Additional file 1: Sequence of synthesized goxB gene with codon
usage optimized for Saccharomyces cerevisiae.
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